Ezra Cohen to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Ezra Cohen has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.398
-
Xevinapant or placebo plus chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck: TrilynX phase III study design. Future Oncol. 2022 May; 18(14):1669-1678.
Score: 0.195
-
Searching for a standard. J Clin Oncol. 2002 Jan 15; 20(2):359-61.
Score: 0.048
-
ONYX-015. Onyx Pharmaceuticals. Curr Opin Investig Drugs. 2001 Dec; 2(12):1770-5.
Score: 0.048
-
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer. Mod Pathol. 2021 03; 34(3):532-541.
Score: 0.045
-
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018 05 01; 29(5):1130-1140.
Score: 0.037
-
The future of induction chemotherapy for head and neck squamous cell carcinoma. Oral Oncol. 2012 Nov; 48(11):1065-7.
Score: 0.025